The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Explore how optometrists can address the impact of screen exposure on myopia progression and educate parents and patients on healthy digital device use.
New Content
Treatment Considerations for Managing Dry Eye Secondary to Systemic Disease
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
Assessing and Managing Retinal Tears as an Optometrist
Sit down with Drs. Daniel Epshtein and Jessica Haynes to review how to identify and stage retinal tears as well as decide when to refer high-risk cases.
The Logistics of Effective Collaborative Care for Glaucoma Management
Join Drs. Preeya K. Gupta, Matt Walker, and Deborah Ristvedt, as they discuss the implementation of collaborative care models for glaucoma management, highlighting the importance of trust and communication between ophthalmologists and referral optometrists.
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Explore how optometrists can address the impact of screen exposure on myopia progression and educate parents and patients on healthy digital device use.
Topics
Why the Best Retina Surgeons Keep Adapting Their Technique
Redefining Durability in nAMD: How nAMD Clinical Trials are Evaluating Durability in New Ways
How Long-Term Durability and Safety are Redefining GA Treatment Decisions
Building Effective OD–Retina Specialist Partnerships: Referral and Co-Management Best Practices
Mild NPDR can progress faster than a “see you in a year” plan allows. Learn to spot the early signs, stage accurately, and recognize the risk factors linked to progression. You’ll also review emerging therapy data, know when to refer, and get practical guidance on documentation, co-management, and building stronger relationships with retina specialists.
Leadership watch: Saunders exits B+L, ZEISS names Vision Care CEO, and other executive moves
Leadership changes are underway in the eyecare space—and we’ve got the latest.
FDA approves Genentech's Enspryng as first at-home TED injection
Subcutaneous version of satralizumab-mwge can be administered by a patient or caregiver following training from an HCP.
Roche reports phase 3 data on steroid-free therapy for UME management
Company announces FDA acceptance of BLA submission as 52-week results find vamikibart demonstrated sustained improvements in vision.
Glaukos reports positive topline phase 4 data on iDose TR in combo with cataract surgery
2026 Retina Report
Download the free report to learn how eyecare professionals are managing retinal disease in 2026!
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
Join Drs. Rishi P. Singh and Mathew MacCumber as they discuss the clinical results of APL-3007 combined with pegcetacoplan for geographic atrophy (GA).
Clinical Specialties
Assessing and Managing Retinal Tears as an Optometrist
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
